La Roche-Posay launches new acne treatment
NEW YORK — In an effort to help those suffering from acne, La Roche-Posay has introduced its new Effaclar K Daily Renovating Anti-Relapse Acne Treatment 1, a daily treatment to address the ongoing, recurring life cycle of acne.
For the first time in a La Roche-Posay product, retinyl linoleate (a vitamin A derivative), salicylic acid and La Roche-Posay's exclusive lipo-hydroxy acid (LHA) molecule are combined to help treat mild acne and prevent its reoccurrence in acne sufferers of all ages.
"While I often recommend a prescription strength retinoid for the treatment of mild acne, some of my patients complain of irritation with regular use," Dr. Hilary Baldwin said. "Incorporating an over-the-counter alternative that minimizes irritation so it can be used every day to both treat acne and prevent it from coming back is an ideal option."
Clinical testing showed a 58% reduction in overall acne imperfections and non-reoccurrence of acne imperfections (two weeks after use), the manufacturer stated.
Effaclar K Daily Renovating Anti-Relapse Acne Treatment 1 is non-comedogenic, paraben-free and dermatologist tested, even on sensitive skin. It is suitable for use on the entire face one to two times daily. Effaclar K Daily Renovating Anti-Relapse Acne Treatment 1 from La Roche-Posay has a suggested retail price of $27.90 and can be purchased at select physicians' offices, select CVS/pharmacy stores, CVS.com, select Walgreens and Duane Reade locations, and online at Laroche-posay.us beginning in July.